HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phil J Ancliff Selected Research

Therapeutics

2/2003Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Phil J Ancliff Research Topics

Disease

4Autosomal Recessive 3 Severe Congenital Neutropenia
10/2006 - 07/2002
1Wiskott-Aldrich Syndrome
03/2009
1X-Linked Severe Congenital Neutropenia
03/2009

Drug/Important Bio-Agent (IBA)

2Leukocyte Elastase (Neutrophil Elastase)IBA
06/2003 - 07/2002
1pancreatic elastase IIIBA
03/2009
1Wiskott-Aldrich Syndrome ProteinIBA
10/2006
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2003

Therapy/Procedure

1Therapeutics
02/2003